Archive:

Aug 15, 2025, 12:00 AM

Clinical perspective on the current burden of melanoma overdiagnosis and its future value for progress in the field of melanoma

Overdiagnosis in melanoma is a nuanced and evolutionary issue. It may appear to be an epidemic from an epidemiological point of view; however, it is important to appreciate all perspectives. We consid…

Read more about 'Clinical perspective on the current burden of melanoma overdiagnosis and its future value for progress in the field of melanoma'...


Phase 1b study of tovorafenib, plozalizumab or vedolizumab plus standard-of-care immune checkpoint inhibitors in patients with advanced melanoma

Background: Novel advanced melanoma therapy combinations may increase treatment efficacy and reduce treatment-related toxicities. Methods: This open-label, nonrandomized, multicenter, phase 1b, 3-a…

Read more about 'Phase 1b study of tovorafenib, plozalizumab or vedolizumab plus standard-of-care immune checkpoint inhibitors in patients with advanced melanoma'...